Search Results - "Kurbatova, Kira A."

Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician’s and patient’s perspectives by Shevchenko, Jury L., Kuznetsov, Alexey N., Ionova, Tatyana I., Melnichenko, Vladimir Y., Fedorenko, Denis A., Kurbatova, Kira A., Gorodokin, Gary I., Novik, Andrei A.

“…High-dose immunosuppressive therapy (HDIT) with autologous hematopoietic stem cell transplantation (AHSCT) is a promising approach to treatment of multiple…”
Get full text

Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis by Shevchenko, Jury L, Kuznetsov, Alexey N, Ionova, Tatyana I, Melnichenko, Vladimir Y, Fedorenko, Denis A, Kartashov, Andrei V, Kurbatova, Kira A, Gorodokin, Gary I, Novik, Andrei A

“…High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation (AHSCT) is a new and promising approach to multiple sclerosis (MS)…”
Get full text

Long-Term Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia from Physician’s and Patient’s Perspective by Ionova, Tatyana I, Nikitina, Tatyana P, Fedorenko, Denis A, Gritsenko, Taras A, Ivanova, Valentina L, Kuchma, Galina B, Shnaider, Tatyana V, Sannikova, Inga V, Usacheva, Elena I, Kurbatova, Kira A

“…Information about the efficacy and safety of the second-line therapy with dasatinib in patients in chronic phase chronic myeloid leukemia (CML-CP) at long-term…”
Get full text

Efficacy Of Dasatinib Therapy In Patients With Imatinib-Resistant Or -Intolerant Chronic Myeloid Leukemia From Physician's and Patient's Perspective: “Real World” Data by Ionova, Tatyana I, Nikitina, Tatyana P, Gritsenko, Taras A, Ivanova, Valentina L, Kuchma, Galina B, Shnaider, Tatyana V, Sannikova, Inga V, Fedorenko, Denis A, Kurbatova, Kira A

“…There is limited published data about the efficacy and safety of the second-line therapy with dasatinib in patients in chronic phase chronic myeloid leukemia…”
Get full text

Clinical and Patient-Reported Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia by Ionova, Tatyana I, Nikitina, Tatiana P, Gritsenko, Taras A, Ivanova, Valentina L, Kuchma, Galina B, Shnaider, Tatyana V, Fedorenko, Denis A, Kurbatova, Kira A, Novik, Andrei A

“…Abstract 4445 Despite remarkable responses with imatinib in chronic phase chronic myeloid leukemia (CML-CP), there remains a proportion of patients who are…”
Get full text

Reduced Intensity Conditioning Regimen of Autologous Hematopoietic Stem Cell Transplantation±Mitoxantrone Consolidation In Multiple Sclerosis by Novik, Andrei A, Kuznetsov, Aleksey N, Melnichenko, Vladimir Y, Fedorenko, Denis A, Kartashov, Andrei V, Ionova, Tatyana I, Kurbatova, Kira A, Gorodokin, Gary I

“…Abstract 372 High-dose immunosuppressive therapy (HDIT) with autologous hematopoietic stem cell transplantation (ASCT) offers promising results in the…”
Get full text

New Instrument for Comprehensive Symptom Profile Assessment In Patients with Malignant Lymphomas by Novik, Andrei A, Ionova, Tatyana I, Kalyadina, Svetlana A, Fedorenko, Denis A, Mochkin, Nikita E, Kurbatova, Kira A, Nikitina, Tatyana P, Gorodokin, Gary I

“…Abstract 2561 Comprehensive symptom assessment before and during treatment in lymphoma patients is worthwhile. We aimed to develop a new symptom assessment…”
Get full text

The Utility of the New Instrument for Comprehensive Symptom Profile Assessment In Patients with Multiple Myeloma by Novik, Andrei A, Ionova, Tatyana I, Kalyadina, Svetlana A, Fedorenko, Denis A, Mochkin, Nikita E, Kurbatova, Kira A, Nikitina, Tatyana P, Gorodokin, Gary I

“…Abstract 4757 Increased importance should be placed on the comprehensive symptom assessment in patients with multiple myeloma to accurately document the broad…”
Get full text